Bank of America’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-94,141
| Closed | -$386K | – | 8786 |
|
|
2022
Q1 | $386K | Sell |
94,141
-101,682
| -52% | -$369K | ﹤0.01% | 6010 |
|
|
2021
Q4 | $699K | Buy |
195,823
+52,213
| +36% | +$183K | ﹤0.01% | 5592 |
|
|
2021
Q3 | $522K | Buy |
143,610
+2,396
| +2% | +$9.69K | ﹤0.01% | 5611 |
|
|
2021
Q2 | $616K | Sell |
141,214
-88,644
| -39% | -$361K | ﹤0.01% | 5263 |
|
|
2021
Q1 | $945K | Buy |
229,858
+26,092
| +13% | +$113K | ﹤0.01% | 4881 |
|
|
2020
Q4 | $813K | Sell |
203,766
-9,768
| -5% | -$31.6K | ﹤0.01% | 4670 |
|
|
2020
Q3 | $577K | Buy |
213,534
+49,958
| +31% | +$138K | ﹤0.01% | 4599 |
|
|
2020
Q2 | $450K | Buy |
163,576
+73,093
| +81% | +$204K | ﹤0.01% | 4698 |
|
|
2020
Q1 | $213K | Sell |
90,483
-28,379
| -24% | -$96.5K | ﹤0.01% | 5044 |
|
|
2019
Q4 | $559K | Sell |
118,862
-87,686
| -42% | -$359K | ﹤0.01% | 4935 |
|
|
2019
Q3 | $691K | Buy |
206,548
+85,604
| +71% | +$282K | ﹤0.01% | 4832 |
|
|
2019
Q2 | $398K | Buy |
120,944
+35,567
| +42% | +$103K | ﹤0.01% | 5215 |
|
|
2019
Q1 | $259K | Sell |
85,377
-16,167
| -16% | -$52.4K | ﹤0.01% | 5399 |
|
|
2018
Q4 | $276K | Buy |
101,544
+53,772
| +113% | +$177K | ﹤0.01% | 5315 |
|
|
2018
Q3 | $161K | Buy |
47,772
+4,391
| +10% | +$13.6K | ﹤0.01% | 5608 |
|
|
2018
Q2 | $112K | Sell |
43,381
-11,176
| -20% | -$27.8K | ﹤0.01% | 5742 |
|
|
2018
Q1 | $120K | Buy |
54,557
+24,943
| +84% | +$56.1K | ﹤0.01% | 5654 |
|
|
2017
Q4 | $58K | Buy |
29,614
+13,836
| +88% | +$30.1K | ﹤0.01% | 6006 |
|
|
2017
Q3 | $51K | Buy |
15,778
+8,354
| +113% | +$25.8K | ﹤0.01% | 5941 |
|
|
2017
Q2 | $24K | Buy |
7,424
+1,289
| +21% | +$3.65K | ﹤0.01% | 6174 |
|
|
2017
Q1 | $17K | Buy |
6,135
+1,133
| +23% | +$2.73K | ﹤0.01% | 6374 |
|
|
2016
Q4 | $12K | Sell |
5,002
-191
| -4% | -$364 | ﹤0.01% | 6511 |
|
|
2016
Q3 | $8K | Sell |
5,193
-46,197
| -90% | -$56.6K | ﹤0.01% | 6469 |
|
|
2016
Q2 | $54K | Buy |
51,390
+48,890
| +1,956% | +$47.2K | ﹤0.01% | 5802 |
|
|
2016
Q1 | $2K | Sell |
2,500
-3,747
| -60% | -$3.63K | ﹤0.01% | 6805 |
|
|
2015
Q4 | $7K | Buy |
6,247
+1,925
| +45% | +$2.68K | ﹤0.01% | 6801 |
|
|
2015
Q3 | $7K | Sell |
4,322
-112,330
| -96% | -$220K | ﹤0.01% | 6687 |
|
|
2015
Q2 | $242K | Buy |
116,652
+113,588
| +3,707% | +$275K | ﹤0.01% | 5143 |
|
|
2015
Q1 | $8K | Sell |
3,064
-24,446
| -89% | -$62K | ﹤0.01% | 6385 |
|
|
2014
Q4 | $71K | Sell |
27,510
-88,597
| -76% | -$199K | ﹤0.01% | 6131 |
|
|
2014
Q3 | $213K | Buy |
116,107
+102,407
| +747% | +$223K | ﹤0.01% | 5335 |
|
|
2014
Q2 | $37K | Sell |
13,700
-29,382
| -68% | -$88.4K | ﹤0.01% | 6858 |
|
|
2014
Q1 | $151K | Buy |
43,082
+38,897
| +929% | +$173K | ﹤0.01% | 5663 |
|
|
2013
Q4 | $19K | Sell |
4,185
-18,873
| -82% | -$76.9K | ﹤0.01% | 7060 |
|
|
2013
Q3 | $94K | Sell |
23,058
-7,295
| -24% | -$31.9K | ﹤0.01% | 6020 |
|
|
2013
Q2 | $126K | Buy |
+30,353
| New | +$117K | ﹤0.01% | 6016 |
|
Other funds holding ATRS
Bank of America's ATRS Position: Q2 2022 in Review
Bank of America sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 94,141 shares — an estimated $386K sold.
Bank of America first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $945K in Q1 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Bank of America reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Bank of America sold 94,141 Antares Pharma, Inc. shares in Q2 2022, an estimated $386K.
- Bank of America first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
- Bank of America's Antares Pharma, Inc. position peaked at $945K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.